ARCHIVES

NIH Slow To Implement Equality In Studies, GAO Says, But Waxman Assures Reauthorization

This article is from The Cancer Letter archive.

Vol. 16 No. 25 | June 22, 1990

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

May 30, 2008

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

Deparle Leaves HCFA; Speyer Promoted At NYU Center.

September 15, 2000

Not All Women Benefitting From Less Invasive Staging

April 25, 2008